glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Bone Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colucci, S; Grano, M; Santacroce, G; Teti, A; Zambonin Zallone, A; Zambonin, G; Zigrino, P | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Bone Cancer
Article | Year |
---|---|
Human osteoclast-like cells recognize laminin via an RGD independent mechanism.
Topics: Amino Acid Sequence; Bone Neoplasms; Cell Adhesion; Fibronectins; Giant Cell Tumor of Bone; Humans; Integrin beta1; Integrins; Laminin; Molecular Sequence Data; Oligopeptides; Osteoclasts; Receptors, Laminin; Tumor Cells, Cultured | 1993 |